Release 8 November, 2019: Sienna and VivaZome to Evaluate EXO-NET(tm) for VivaZome’s Exosome-based Therapeutics

Vivazome – Sienna Collaboration release 8 Nov 2019


Media Release 30 October, 2019:  David Haylock, PhD Appointed as Chief Executive Officer

VivaZome release 30 Oct 2019 David Haylock to CEO


Media Release 27 August 2019: Collaborative Research Agreement between VivaZome Pty Ltd and ToolGen, Inc.

VivaZome – ToolGen release FINAL 27Aug2019


 Media Release  14 August 2019: Dr David Haylock joins VivaZome Therapeutics as Chief Scientific Officer; Manufacturing development work begins at CSIRO.

VivaZome release Haylock – CSIRO 14 August 2019 FINAL


Media Release  18 December 2017: $2.18m grant awarded to VivaZome Therapeutics for Exosome Therapy

VivaZome CRC-P Media Release 18th Dec 2017 final